jueves, 31 de agosto de 2023

The Pursuing Excellence Collaborative: engaging first-year residents and fellows in patient safety event investigations.

https://psnet.ahrq.gov/issue/pursuing-excellence-collaborative-engaging-first-year-residents-and-fellows-patient-safety Previous research suggests that residents may underutilize adverse event reporting tools. This article describes an 18-month clinical learning collaborative among 16 sites intended to increase resident and fellow participation in patient safety event investigations. Researchers found the collaborative increased participation in event investigation and improved the quality of the investigation.

Mind the power gap: how hierarchical leadership in healthcare is a risk to patient safety.

https://psnet.ahrq.gov/issue/mind-power-gap-how-hierarchical-leadership-healthcare-risk-patient-safety Hierarchy as an organizational or team structure is known to affect patient safety. This editorial examines the impact a strict chain of command can have on communication and awareness-raising actions in the care environment. The author illustrates how a staff’s ability to contribute to care goals and raise concerns is enhanced when all are respected as having valuable insights without deference to role or education level.

Quality and safety practices among academic obstetrics and gynecology departments.

https://psnet.ahrq.gov/issue/quality-and-safety-practices-among-academic-obstetrics-and-gynecology-departments Staff engagement in safety and quality improvement efforts fosters a culture of safety and can reduce medical errors. This survey of 52 obstetrics and gynecology departments at academic medical centers found that few departments provided faculty with protected time or financial support for quality improvement activities, and only 5% of departments included a patient representative on the quality committee.

Opportunities to improve diagnosis in emergency transfers to the pediatric intensive care unit.

https://psnet.ahrq.gov/issue/opportunities-improve-diagnosis-emergency-transfers-pediatric-intensive-care-unit Improving diagnosis in pediatrics is an ongoing patient safety focus. This retrospective study included 129 pediatric emergency transfer cases and examined the relationship between missed opportunity for improvement in diagnosis (MOID; determined using SaferDx) and patient outcomes. Researchers found that MOID occurred in 29% of emergency transfer cases and it was associated with higher risk of mortality and longer post-transfer length of stay.v

Healthcare fragmentation, multimorbidity, potentially inappropriate medication, and mortality: a Danish nationwide cohort study.

https://psnet.ahrq.gov/issue/healthcare-fragmentation-multimorbidity-potentially-inappropriate-medication-and-mortality System weaknesses (e.g., resource availability, deficiencies in care coordination) threaten patient safety. This population-based cohort study including 4.7 million Danish adults who interacted with primary or hospital care in 2018, found that indicators of care fragmentation (e.g., higher numbers of involved clinicians, more transitions between providers) increased with patient morbidity level. The researchers found that higher levels of care fragmentation were associated with adverse outcomes, including potentially inappropriate prescribing and mortality.

Exploring the impact of safety culture on incident reporting: lessons learned from machine learning analysis of NHS England staff survey and incident data.

https://psnet.ahrq.gov/issue/exploring-impact-safety-culture-incident-reporting-lessons-learned-machine-learning-analysis Voluntary incident reporting rates may be an indicator of organizational safety culture. Using different machine learning algorithms, this study found that several components of safety culture – compassionate culture, violence and harassment, and work pressure – have a significant impact on predicting incident reporting behavior.

Exploring medication safety structures and processes in nursing homes: a cross-sectional study.

https://psnet.ahrq.gov/issue/exploring-medication-safety-structures-and-processes-nursing-homes-cross-sectional-study Effective implementation of health information technology can promote medication safety. This survey of 118 nursing homes in Switzerland found that organizations employ a variety of electronic health record (EHR)-based tools to support medication safety, such as standardized medication lists, alerts for potentially inappropriate prescribing, or electronic data exchanges with community pharmacies or outside physicians.

Estimating breast cancer overdiagnosis after screening mammography among older women in the United States.

https://psnet.ahrq.gov/issue/estimating-breast-cancer-overdiagnosis-after-screening-mammography-among-older-women-united Overdiagnosis can result in overtreatment, physical harm, and emotional distress. Using SEER-Medicare data, researchers examined breast cancer overdiagnosis by comparing cancer incidence among women who discontinued mammography screening after age 70 compared to women who continued to receive screening mammograms. Findings suggest that breast cancer may be potentially overdiagnosed among 31% of women aged 70 to 74 years, 47% of women aged 75 to 84 years, and 54% of women aged 85 and older who continue to receive screening mammograms.

Effect of lawsuits on professional well-being and medical error rates among orthopaedic surgeons.

https://psnet.ahrq.gov/issue/effect-lawsuits-professional-well-being-and-medical-error-rates-among-orthopaedic-surgeons Previous analyses have found that orthopedic surgery is one common source of patient harm. This survey of 305 orthopedists found that involvement in a medical malpractice lawsuit within the past two years increased the likelihood of experiencing burnout and reporting a medical error resulting in patient harm in the past year.

Activating pharmacists to reduce the frequency of medication-related problems (ACTMed): a stepped wedge cluster randomised trial.

https://psnet.ahrq.gov/issue/activating-pharmacists-reduce-frequency-medication-related-problems-actmed-stepped-wedge Medication safety in ambulatory care settings is an area of growing concern. This article describes ACTMed (ACTivating primary care for MEDicine safety), a cluster randomized trial set in Australia which intends to improve medication safety in primary care settings. The ACTMed intervention will use health information technology (e.g., clinical indicator algorithms), guideline-based clinical recommendations, shared decision-making, and financial incentives to reduce serious medication-related harm, medication-related hospitalizations, and death.

A natural language processing approach to categorise contributing factors from patient safety event reports.

https://psnet.ahrq.gov/issue/natural-language-processing-approach-categorise-contributing-factors-patient-safety-event Analyzing patient safety incident reports is essential to organizational learning, but comes with both a time and financial burden. This study found that natural language processing can be used to process unstructured patient safety event reports and reduce the burden of manually identifying and extracting factors contributing to the event.

Anesthesia Risk Alert program: a proactive safety initiative.

https://psnet.ahrq.gov/issue/anesthesia-risk-alert-program-proactive-safety-initiative Lee B, Marhalik-Helms J, Penzi L. Jt Comm J Qual Patient Saf. 2023;49(9):441-449. Perioperative and anesthesia care present unique patient safety challenges. This article describes the development and implementation of the Anesthesia Risk Alert (ARA) program, which promotes collaborative clinical decision-making and recommends risk mitigation strategies to address specific high-risk clinical scenarios. Since implementation began in 2019, ARA compliance has exceeded 90% and has reduced the rate of adverse events among certain high-risk patients, such as those with a high body mass index

Diagnostic reliability in teledermatology: a systematic review and a meta-analysis.

https://psnet.ahrq.gov/issue/diagnostic-reliability-teledermatology-systematic-review-and-meta-analysis Bourkas AN, Barone N, Bourkas MEC, et al. BMJ Open. 2023;13(8):e068207. Telemedicine can improve access to specialist care and reduce time to treatment. This systematic review including 44 articles examined the diagnostic agreement between teledermatology and face-to-face consults. The overall average diagnostic agreement was 68.9%, but subgroup analyses identified significantly higher agreement when dermatologists conducted face-to-face and teledermatology consults, rather than non-specialists (i.e., primary care or emergency medicine physicians).

Just what the doctor ordered: missed ordering of venous thromboembolism chemoprophylaxis is associated with increased VTE events in high-risk general surgery patients.

https://psnet.ahrq.gov/issue/just-what-doctor-ordered-missed-ordering-venous-thromboembolism-chemoprophylaxis-associated Baimas-George MR, Ross SW, Yang H, et al. Ann Surg. 2023;278(3):e614-e619. Hospital-acquired venous thromboembolism (VTE) remains a significant source of preventable patient harm. This study of 4,252 high-risk general surgery patients found that only one-third received care in compliance with VTE prophylaxis guidelines. Patients receiving guideline-compliant care experienced shorter lengths of stay (LOS), fewer blood transfusions, and decreased odds of having a VTE, emphasizing the importance of initiating VTE chemoprophylaxis in high-risk general surgery patients.

The Future of Prescription Drug Promotion and Digital Marketing September 14, 2023 12:30 - 5:00 PM ET Virtually via Zoom

The Future of Prescription Drug Promotion and Digital Marketing September 14, 2023 12:30 - 5:00 PM ET Virtually via Zoom The digital marketing landscape is a dynamic and rapidly evolving ecosystem, and marketers have a growing array of communication channels to promote products to consumers. It is important to understand how current and emerging trends in digital marketing may impact information conveyed to various audiences in prescription drug promotional materials. The Duke-Margolis Center for Health Policy, under a cooperative agreement with the FDA, is convening a workshop on Thursday, September 14 that will explore the state of digital prescription drug promotion, including the technologies and strategies currently available to and commonly used by marketers. Participants will learn more about the following topics: The impact of current and future digital marketing tools on patient, health care provider, and consumer perceptions and behaviors. The presentation of risk information and disclosures of material information necessary to ensure that the prescription drug promotion is truthful and not misleading. Emerging trends in both digital and legacy marketing channels, and what those trends may mean for public health. A draft agenda is currently available on the event webpage and will be updated with further details as they are confirmed. To attend this event, please register below: Register to Attend Virtually https://duke.zoom.us/webinar/register/WN_xZ417Gk6SuaD2qSyVoe-vg?utm_medium=email&utm_source=govdelivery#/registration

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry AUGUST 2023

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry AUGUST 2023 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug

Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act Guidance for Industry AUGUST 2023

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enhanced-drug-distribution-security-package-level-under-drug-supply-chain-security-act

DSCSA compliance policies establish 1-year stabilization period for implementing electronic systems

DSCSA compliance policies establish 1-year stabilization period for implementing electronic systems https://www.fda.gov/drugs/drug-safety-and-availability/dscsa-compliance-policies-establish-1-year-stabilization-period-implementing-electronic-systems

Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies SEPTEMBER 2023

Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies SEPTEMBER 2023 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/wholesale-distributor-verification-requirement-saleable-returned-drug-product-and-dispenser-0

miércoles, 30 de agosto de 2023

Compliance with central line maintenance bundle and infection rates.

https://psnet.ahrq.gov/issue/compliance-central-line-maintenance-bundle-and-infection-rates

Clinicians' insights on emergency department boarding: an explanatory mixed methods study evaluating patient care and clinician well-being.

https://psnet.ahrq.gov/issue/clinicians-insights-emergency-department-boarding-explanatory-mixed-methods-study-evaluating

Common contributing factors of diagnostic error: a retrospective analysis of 109 serious adverse event reports from Dutch hospitals.

https://psnet.ahrq.gov/issue/common-contributing-factors-diagnostic-error-retrospective-analysis-109-serious-adverse-event

The National Action Alliance To Advance Patient Safety: Register Now: Sept. 26 Webinar on Learning Health System’s Potential To Reduce Patient Harms

The National Action Alliance To Advance Patient Safety: The Agency for Healthcare Research and Quality (AHRQ), on behalf of the Department of Health and Human Services (HHS), has established the National Action Alliance to Advance Patient Safety as a public-private collaboration to improve both patient and workforce safety. The National Action Alliance is a partnership between HHS and its Federal agencies and private stakeholders, including healthcare systems, clinicians, allied health professionals, patients, families, caregivers, professional societies, patient and workforce safety advocates, the digital healthcare sector, health services researchers, employers, and payors interested in recommitting our Nation to advancing patient and workforce safety to move toward zero harm in healthcare.

2023 NanoDay Symposium: Continuous Manufacturing of Nanomaterials OCTOBER 11, 2023

2023 NanoDay Symposium: Continuous Manufacturing of Nanomaterials OCTOBER 11, 2023 https://www.fda.gov/drugs/news-events-human-drugs/2023-nanoday-symposium-continuous-manufacturing-nanomaterials-10112023?utm_medium=email&utm_source=govdelivery In this symposium, FDA will provide an overview of CDER experience with approving several solid oral drug products which benefited from the continuous manufacturing technologies https://sbiaevents.com/files2023/NanoDay-2023-Agenda.pdf?utm_medium=email&utm_source=govdelivery

AHRQ’s CAHPS Program: Addressing Emerging Needs for Patient Experience Measurement and Improvement (Webcast)

AHRQ’s CAHPS Program: Addressing Emerging Needs for Patient Experience Measurement and Improvement (Webcast): This webcast is about how the agency’s CAHPS Consortium is addressing survey stakeholders’ emerging needs for patient experience measurement and improvement.

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry AUGUST 2023

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry AUGUST 2023 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug?utm_medium=email&utm_source=govdelivery

Care Management

Care Management: Care management tools and resources for primary care patients with chronic conditions and other problems.

Care Coordination

Care Coordination: Research, tools and resources to improve care coordination in primary care.

EvidenceNOW Tools for Change

EvidenceNOW Tools for Change: Browse the topics below to access EvidenceNOW tools and materials.

Practice-based Research Networks

Practice-based Research Networks: AHRQ's primary care practice-based research networks (PBRNs) across 50 states are groups of primary care clinicians and practices that use clinicians' insights and experience to identify research questions, which when translated into primary care practice can improve quality of primary care.

Webinar Series: Strengthening Primary Care Research

Webinar Series: Strengthening Primary Care Research: This series of webinars focuses on how to strengthen AHRQ’s primary research. For recordings of the presentations and slides, reference the webinars. Registration is open for an AHRQ webinar on Sept. 14 from 1:30 to 2:45 p.m. ET on Innovative Use of Technology in Primary Care Delivery. The webinar, hosted by AHRQ’s National Center for Excellence in Primary Care Research, will feature AHRQ grantees discussing their research on engaging patients in event reporting, improving medication safety for medically complex children with mHealth and improving diabetes and depression self-management via adaptive mobile messaging. Researchers will discuss future uses of new technologies and answer attendee questions.

National Center for Excellence in Primary Care Research

National Center for Excellence in Primary Care Research: AHRQ’s research to advance primary care infrastructure, delivery and outcomes. The National Center for Excellence in Primary Care Research (NCEPCR) is the intellectual home for primary care research at AHRQ. The NCEPCR is focused on the Nation's primary care system, providing evidence, practical tools, and other resources for researchers and evaluators, clinicians and clinical teams, quality improvement experts, and healthcare decision makers to improve the quality and safety of care. The NCEPCR is committed to listening to and learning from all members of the primary care community, including patients and families.

TeamSTEPPS 3.0 Welcome Guides

TeamSTEPPS 3.0 Welcome Guides: TeamSTEPPS is an evidence-based framework to optimize team performance across the healthcare delivery system. It is recommended to start with the welcome guide for your role.

TeamSTEPPS Updates

TeamSTEPPS Updates: The Agency for Healthcare Research and Quality updated TeamSTEPPS in 2023 to address changes in healthcare delivery and learning methods and to emphasize active patient involvement in their care.

Additional Videos for TeamSTEPPS 3.0

Additional Videos for TeamSTEPPS 3.0

TeamSTEPPS Training Simulation Videos

TeamSTEPPS Training Simulation Videos: Video-based simulation training is an easy-to-use method for teams to practice applying TeamSTEPPS principles to real scenarios. The goal of these trainings is for teams to be able to identify TeamSTEPPS principles/tools that promote effective teamwork and then apply these principles in day-to-day clinical work.

TeamSTEPPS Patient Videos

TeamSTEPPS Patient Videos

TeamSTEPPS 3.0 Curriculum Materials

TeamSTEPPS 3.0 Curriculum Materials: TeamSTEPPS 3.0 curriculum includes the introduction, four modules, and the implementation section.

AHRQ Challenge on Innovative Solutions To Update or Re-Create TeamSTEPPS Videos

AHRQ Challenge on Innovative Solutions To Update or Re-Create TeamSTEPPS Videos

Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19

https://pubmed.ncbi.nlm.nih.gov/36602804/ AHRQ Stats: Hospitalizations for COVID-19–Related Multisystem Inflammatory Syndrome in Children Hospitalizations for COVID-19–related multisystem inflammatory syndrome in children varied significantly by race in 2021, ranging from 0.97 hospitalizations per every 100,000 White children per month to 1.99 hospitalizations per every 100,000 Black children per month. (Source: JAMA Network Open.)

martes, 29 de agosto de 2023

Sentinel Event Alert 67: Preserving Patient Safety After a Cyberattack.

https://psnet.ahrq.gov/issue/sentinel-event-alert-67-preserving-patient-safety-after-cyberattack

Handling injectable medications in anaesthesia: Guidelines from the Association of Anaesthetists.

https://psnet.ahrq.gov/issue/handling-injectable-medications-anaesthesia-guidelines-association-anaesthetists

Five new ways to advance diagnostic safety in your clinical practice.

https://psnet.ahrq.gov/issue/five-new-ways-advance-diagnostic-safety-your-clinical-practice

Differential perceptions of what constitutes a medical error associated with electronic medical records.

https://psnet.ahrq.gov/issue/differential-perceptions-what-constitutes-medical-error-associated-electronic-medical-records

Addressing structural racism in pediatric clinical practice.

https://psnet.ahrq.gov/issue/addressing-structural-racism-pediatric-clinical-practice

Study highlights the economic burden of cardiovascular diseases in the European Union

https://www.news-medical.net/news/20230828/Study-highlights-the-economic-burden-of-cardiovascular-diseases-in-the-European-Union.aspx

She paid her husband’s hospital bill. A year after his death, they wanted more money.

https://www.news-medical.net/news/20230829/She-paid-her-husbande28099s-hospital-bill-A-year-after-his-death-they-wanted-more-money.aspx

Omicron's dominance amidst immune escape sparks debate: should it be classified as a separate serotype?

https://www.news-medical.net/news/20230829/Omicrons-dominance-amidst-immune-escape-sparks-debate-should-it-be-classified-as-a-separate-serotype.aspx

Analysis reveals limited evidence on use of cannabis products in children with cancer

https://www.news-medical.net/news/20230829/Analysis-reveals-limited-evidence-on-use-of-cannabis-products-in-children-with-cancer.aspx

Exclusive: CMS study sabotages efforts to bolster nursing home staffing, advocates say

https://www.news-medical.net/news/20230829/Exclusive-CMS-study-sabotages-efforts-to-bolster-nursing-home-staffing-advocates-say.aspx

Are we failing to bridge the gap in HPV vaccine coverage globally?

https://www.news-medical.net/news/20230829/Are-we-failing-to-bridge-the-gap-in-HPV-vaccine-coverage-globally.aspx

Public Workshop to Enhance Clinical Study Diversity

https://duke.zoom.us/meeting/register/tJcrceuhqjgvE9zGjDNOURONoJZvxrpK4Rvi?utm_medium=email&utm_source=govdelivery#/registration The U.S. Food and Drug Administration (FDA) is announcing a public meeting/workshop entitled Public Workshop to Enhance Clinical Study Diversity. The purpose of this public workshop is to solicit input on increasing the enrollment of historically underrepresented populations in clinical studies and encouraging clinical study participation that reflects the prevalence of the disease or condition among demographic subgroups. Workshop Date: Wednesday, November 29 and Thursday, November 30, 2023 Location: This workshop is virtual. Link will be available after registering. Registration is now open!

OPDP Coming Out! New Untitled Letter, Old Issue By Dara Katcher Levy —

https://www.thefdalawblog.com/2023/08/opdp-coming-out-new-untitled-letter-old-issue/?utm_source=rss&utm_medium=rss&utm_campaign=opdp-coming-out-new-untitled-letter-old-issue

Trading Partners May Exhale: FDA Releases Guidance Exercising a Year-Long Period of Enforcement Discretion Related to DSCSA Enforcement of Certain Provisions August 28, 2023 By Karla L. Palmer —

https://www.thefdalawblog.com/2023/08/trading-partners-may-exhale-fda-releases-guidance-exercising-a-year-long-period-of-enforcement-discretion-related-to-dscsa-enforcement-of-certain-provisions/?utm_source=rss&utm_medium=rss&utm_campaign=trading-partners-may-exhale-fda-releases-guidance-exercising-a-year-long-period-of-enforcement-discretion-related-to-dscsa-enforcement-of-certain-provisions

Wearables, Sensors, and Apps Part 1 – Updates on FDA’s PDUFA VII Goals for the Use of Digital Health Technologies in Drug and Biological Product Development August 24, 2023 By Adrienne R. Lenz, Principal Medical Device Regulation Expert —

https://www.thefdalawblog.com/2023/08/wearables-sensors-and-apps-part-1-updates-on-fdas-pdufa-vii-goals-for-the-use-of-digital-health-technologies-in-drug-and-biological-product-development/?utm_source=rss&utm_medium=rss&utm_campaign=wearables-sensors-and-apps-part-1-updates-on-fdas-pdufa-vii-goals-for-the-use-of-digital-health-technologies-in-drug-and-biological-product-development

Fourteen HP&M Attorneys Recognized by Best Lawyers® in 2024 in America August 25, 2023

https://www.thefdalawblog.com/2023/08/fourteen-hpm-attorneys-recognized-by-best-lawyers-in-2024-in-america/?utm_source=rss&utm_medium=rss&utm_campaign=fourteen-hpm-attorneys-recognized-by-best-lawyers-in-2024-in-america

Wearables, Sensors, and Apps Part 2 – Development and Qualification of Digital Health Technologies in Drug and Biological Product Development By Adrienne R. Lenz, Principal Medical Device Regulation Expert —

Wearables, Sensors, and Apps Part 2 – Development and Qualification of Digital Health Technologies in Drug and Biological Product Development By Adrienne R. Lenz, Principal Medical Device Regulation Expert — https://www.thefdalawblog.com/2023/08/wearables-sensors-and-apps-part-2-development-and-qualification-of-digital-health-technologies-in-drug-and-biological-product-development/?utm_source=rss&utm_medium=rss&utm_campaign=wearables-sensors-and-apps-part-2-development-and-qualification-of-digital-health-technologies-in-drug-and-biological-product-development

Here are the 10 drugs that will be up first for Medicare price negotiation Rachel Cohrs Matthew Herper By Rachel Cohrs and Matthew Herper Aug. 29, 2023

https://www.statnews.com/2023/08/29/10-drugs-medicare-price-negotiation/?utm_campaign=breaking_news&utm_medium=email&_hsmi=272122640&_hsenc=p2ANqtz-8dxwMZkyy0B2zxc788MVYw664y9lAJcRyRiRvVNpnMdc9KykdYubrRnEEbj6WQM_mVKqLoTFddwQssHNrRj0EOtDnrXA&utm_content=272122640&utm_source=hs_email

What’s New for Biologics

https://www.fda.gov/vaccines-blood-biologics/news-events-biologics/whats-new-biologics?utm_medium=email&utm_source=govdelivery

September 6, 2023: Patient Engagement Advisory Committee Meeting Announcement SEPTEMBER 6, 2023

Reminder: Patient Engagement Advisory Committee (PEAC) Virtual Meeting on Advancing Health Equity in Medical Devices https://www.fda.gov/advisory-committees/advisory-committee-calendar/september-6-2023-patient-engagement-advisory-committee-meeting-announcement-09062023?utm_medium=email&utm_source=govdelivery

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Primary Care Interventions to Prevent Child Maltreatment

https://www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/opportunity-for-public-comment The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on primary care interventions to prevent child maltreatment. The Task Force is calling for more research on how to prevent child maltreatment before it occurs in children and adolescents who do not show signs or symptoms of abuse and neglect. The draft recommendation statement and draft evidence review are available for review and public comment from August 29, 2023 to September 25, 2023 here.

Compounding Training Available: Outsourcing Facility Guide

Compounding Training Available: Outsourcing Facility Guide https://www.train.org/main/course/1091111/details?utm_medium=email&utm_source=govdelivery The FDA Compounding Quality Center of Excellence is announcing the availability of a self-guided online course to support outsourcing facilities and other stakeholders in their efforts to enhance the quality of compounded drugs. This course highlights important regulatory information about requirements specific to outsourcing facilities such as: registration, adverse event reporting, requirements section 503B of the FD&C Act, and major topics covered in key guidance documents.

Behavioral Health Equity Challenge Winners Showcase Thursday, September 7, 2:30 - 4 p.m. ET

Behavioral Health Equity Challenge Winners Showcase Thursday, September 7, 2:30 - 4 p.m. ET https://us02web.zoom.us/webinar/register/WN_5MqhErDtTb2vp_hm6LwrFw?utm_source=SAMHSA&utm_campaign=5599e0dca2-EMAIL_CAMPAIGN_2023_08_24_02_21&utm_medium=email&utm_term=0_-5599e0dca2-%5BLIST_EMAIL_ID%5D#/registration Earlier this year, the Substance Abuse and Mental Health Services Administration (SAMHSA) launched the "Behavioral Health Equity Challenge: Outreach and Engagement Strategies for Underserved Racial and Ethnic Communities." Community-based organizations (CBOs) often serve on the front lines to address the needs of their community members. The goal of this challenge was to identify and highlight outreach and engagement strategies CBOs use to increase access to behavioral health services for racially and ethnically diverse, underserved communities. Join this Showcase to hear from the winners of the Behavioral Health Equity Challenge! Winners will share their innovative strategies, lessons learned from implementation, and recommendations for replication in other communities. SAMHSA invites CBOs, state and federal leaders, and behavioral health leaders to join the Showcase to learn from and engage in Q&A with Challenge Winners.

lunes, 28 de agosto de 2023

Status of patient safety culture in community pharmacy settings: a systematic review.

https://psnet.ahrq.gov/issue/status-patient-safety-culture-community-pharmacy-settings-systematic-review

Anaesthesia and patient safety in the socio-technical operating theatre: a narrative review spanning a century.

https://psnet.ahrq.gov/issue/anaesthesia-and-patient-safety-socio-technical-operating-theatre-narrative-review-spanning

Nearly all hospital pharmacists say drug shortages are negatively impacting care; a third say impacts are ‘critical.’

https://psnet.ahrq.gov/issue/nearly-all-hospital-pharmacists-say-drug-shortages-are-negatively-impacting-care-third-say

Indian Health Service: Actions Needed to Improve Use of Data on Adverse Events.

https://psnet.ahrq.gov/issue/indian-health-service-actions-needed-improve-use-data-adverse-events

Covering Health: Patient Safety.

https://psnet.ahrq.gov/issue/covering-health-patient-safety

Unstoppable: this doctor has been investigated at every level of government. How is he still practicing?

https://psnet.ahrq.gov/issue/unstoppable-doctor-has-been-investigated-every-level-government-how-he-still-practicing

Join Us for the National Center on Substance Abuse and Child Welfare’s (NCSACW) Upcoming Webinar and “Dialogue with Experts” Series: Emerging Drug Trends and the Effects on Safety and Risk to Children and Parents Thursday, August 31, 2 - 3:30 p.m. ET

https://cffutures.zoom.us/webinar/register/WN_NVWpTM6ER-K1MdC2kHZH-g?utm_source=SAMHSA&utm_campaign=526b53f8bc-EMAIL_CAMPAIGN_2023_08_11_03_35_COPY_01&utm_medium=email&utm_term=0_-8fec6a8684-%5BLIST_EMAIL_ID%5D#/registration

Regulating AI in Pharmaceuticals: Stakeholders Weigh In Till End of December

https://www.univadis.com/viewarticle/regulating-ai-pharmaceuticals-stakeholders-weigh-till-end-2023a1000iha?uac=148436CN&ecd=mkm_ret_230827_uni-OUS_SPECIAL_etid5184324&u=&utm_source=&utm_medium=email&utm_campaign=adhoc_ous_special-aimedicine_20230827_ann-amer&utm_content=5184324&utm_term=&sso=true

CDER Small Business and Industry Assistance (SBIA) presents Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2023

CDER Small Business and Industry Assistance (SBIA) https://www.fda.gov/drugs/news-events-human-drugs/electronic-drug-registration-and-listing-edrls-using-cder-direct-2023-09282023?utm_medium=email&utm_source=govdelivery presents Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2023 https://sbiaevents.com/files2023/eDRLS-2023-Agenda.pdf?utm_medium=email&utm_source=govdelivery

Trading Partners May Exhale: FDA Releases Guidance Exercising a Year-Long Period of Enforcement Discretion Related to DSCSA Enforcement of Certain Provisions August 28, 2023 By Karla L. Palmer —Trading Partners May Exhale: FDA Releases Guidance Exercising a Year-Long Period of Enforcement Discretion Related to DSCSA Enforcement of Certain Provisions August 28, 2023 By Karla L. Palmer —

Trading Partners May Exhale: FDA Releases Guidance Exercising a Year-Long Period of Enforcement Discretion Related to DSCSA Enforcement of Certain Provisions August 28, 2023 By Karla L. Palmer — https://www.thefdalawblog.com/2023/08/trading-partners-may-exhale-fda-releases-guidance-exercising-a-year-long-period-of-enforcement-discretion-related-to-dscsa-enforcement-of-certain-provisions/?utm_source=rss&utm_medium=rss&utm_campaign=trading-partners-may-exhale-fda-releases-guidance-exercising-a-year-long-period-of-enforcement-discretion-related-to-dscsa-enforcement-of-certain-provisions

CDER Small Business and Industry Assistance (SBIA) Presents Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials

CDER Small Business and Industry Assistance (SBIA) Presents https://www.fda.gov/drugs/news-events-human-drugs/use-biomarkers-diagnosing-and-assessing-treatment-response-noncirrhotic-nash-trials-09182023?utm_medium=email&utm_source=govdelivery Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials https://www.fda.gov/media/171426/download?attachment=&utm_medium=email&utm_source=govdelivery

Public Meeting on the Recommendations for Over-the-Counter Monograph Drug User Fee Program (OMUFA) September 28, 2023

https://www.fda.gov/drugs/news-events-human-drugs/public-meeting-recommendations-over-counter-monograph-drug-user-fee-program-omufa-september-28-2023?check_logged_in=1&utm_medium=email&utm_source=govdelivery

Global Mental Health Research Listening Sessions

Global Mental Health Research Listening Sessions https://gmhrlisteningsessions.com/ September 18, 2023 9:00–10:30 a.m. ET September 19, 2023 10:00–11:30 p.m. ET The National Institute of Mental Health’s (NIMH) Global Mental Health Team is hosting a series of listening sessions to hear the perspectives and experiences of individuals involved in mental health research across a range of career stages and roles, including investigators, research staff, grants management and administrative staff, and policymakers. We are particularly interested in hearing from individuals who are from low- and middle-income countries (LMICs) or who are currently working at LMIC institutions, as well as from those in under-resourced communities. During these sessions, the Global Mental Health Team hopes to gather insights and experiences about various aspects of mental health research, such as institutional capacity building, training, building independent careers, mentorship, applying for and managing grants, forming partnerships and collaborations, investing in long-term projects, and ensuring the relevance of mental health research in real-world practice. Sessions will be held between mid-September and late October. Each session will offer 9:00 a.m. – 10:30 a.m. ET and 10:00 p.m. – 11:30 p.m. ET time slots to accommodate time differences. If you are interested in participating in a session, please register online. https://www.nimh.nih.gov/news/events/announcements/global-mental-health-research-listening-sessions

Audio Transcript | Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products

https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/audio-transcript-insights-about-fdaema-parallel-scientific-advice-program-complex-generichybrid-drug?utm_medium=email&utm_source=govdelivery

FDA D.I.S.C.O. Burst Edition: FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-epkinly-epcoritamab-bysp-relapsed-or-refractory-diffuse-large-b?utm_medium=email&utm_source=govdelivery

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-updating-warnings-improve-safe-use-prescription-stimulants-used-treat-adhd-and-other-conditions?utm_medium=email&utm_source=govdelivery

CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito

https://www.fda.gov/drugs/news-events-human-drugs/cure-id-tool-clinicians-report-new-uses-existing-drugs-heather-stone-and-dr-marco-schito?utm_medium=email&utm_source=govdelivery

What is a Supernatant?

https://www.news-medical.net/life-sciences/What-is-a-Supernatant.aspx

Recent Technological Advancements in Medicines Manufacturing

https://www.news-medical.net/life-sciences/Recent-Technological-Advancements-in-Medicines-Manufacturing.aspx

Undruggable: The Current State of Drugging Cancer Targets

https://www.news-medical.net/life-sciences/Undruggable-The-current-state-of-drugging-cancer-targets.aspx

Insights into COVID-19's aftermath: 2-year study examines lasting health effects

https://www.news-medical.net/news/20230828/Insights-into-COVID-19s-aftermath-2-year-study-examines-lasting-health-effects.aspx

Indigenous women living "off reserve" face many disparities in health care access

https://www.news-medical.net/news/20230828/Indigenous-women-living-off-reserve-face-many-disparities-in-health-care-access.aspx

domingo, 27 de agosto de 2023

Pharmacogenomics and the Management of Mood Disorders—A Review KK Schaars et al, J Per Med, July 24, 2023

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=pgx&query=home

Transdisciplinary Conference for Future Leaders in Precision Public Health, November 9, 2023 UNC Chapel Hill, Virtual Meeting, November 9, 2023

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=Implementation&query=home

Digital PCR: A Partitioning-Based Application for Detection and Surveillance of SARS-CoV-2 from Sewage Samples. External Web Site Icon Prajapati Bhumika, et al. Methods in molecular biology (Clifton, N.J.) 2023 0 0. 1-16

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=environmental&query=home

Factors influencing genetic screening enrollment among a diverse, community-ascertained cohort: Factors influencing genetic screening enrollment ND Rao et al, Public Health Genomics, August 21, 2023

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=equity&query=home

Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension. Ruben Willems et al. NPJ Digit Med 2023 8 (1) 150

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=economic&query=home

Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation November 30, 2023, 12:00 pm – 1:00 pm ETv

Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation November 30, 2023, 12:00 pm – 1:00 pm ET https://www.cdc.gov/genomics/events/rapid_gen_test_2023.htm

Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings, Methodologic Issues, and the Path Forward October 26, 2023, 11:00 am – 12:00 pm ET

Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings, Methodologic Issues, and the Path Forward October 26, 2023, 11:00 am – 12:00 pm ET https://www.cdc.gov/genomics/events/cost_effectiveness_2023.htm

The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health: Where Are we Heading with Preemptive Pharmacogenomic Screening?

The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health: Where Are we Heading with Preemptive Pharmacogenomic Screening? September 14, 2023, 12:00 pm – 1:00 pm ET Individual variability in drug response efficacy or safety is becoming an increasing problem globally, given the growing population of older adults. Reasons for this variability include genomic factors, an area of study called pharmacogenomics. With genotyping technologies now widely available and decreasing in cost, implementing pharmacogenomics into clinical practice is widely viewed as an initial step in mainstreaming genomic medicine. The benefits of pharmacogenomic testing before starting drug therapy has been well documented for several single gene-drug combinations. In addition, the clinical utility of a pre-emptive genotyping strategy using a pharmacogenetic panel is being rigorously assessed. However, major challenges of implementation lie at the point of integration into healthcare systems, including the modification of clinical pathways and a large knowledge gap in pharmacogenomics in the healthcare workforce. Pharmacogenomics can also be used in a broader sense for drug discovery and development, with increasing evidence suggesting that genomically defined targets have an increased success rate during clinical development. Our speaker will review recent developments in the field of pharmacogenomics and the ongoing challenges in equitable translation of discoveries into clinical practice and public health programs. https://www.cdc.gov/genomics/events/pharma_2023.htm

Get up to Speed on the Latest Developments in the Field! Register for the ORISE Current Issues in Genomics and Precision Public Health Online Training Event, September 7–8, 2023.

https://blogs.cdc.gov/genomics/2023/08/09/get-up-to-speed/ Advances in genomics, data science, machine learning, and artificial intelligence are transforming practice. Next generation public health and medical workforces need to understand these developments and how they can be used to benefit population health.

Genomics and Precision Public Health, Atlanta, September 7- 8, 2023

https://orise.orau.gov/news/events/cdc-genomics-and-precision-public-health-issues-enrichment-event.html This week, we spotlight our upcoming training event in collaboration with Oak Ridge Institute for Science and Education, Atlanta, September 7-8, 2023. The in-person and online course is targeted toward trainees in public health as an introduction to concepts and approaches of genomics, big data and precision health for improving health care and population health.

Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00232-3/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz--stl1UWkKUfi08lLC1RSa5wh-Wik4TWKlycVldU1uIqQv5_ajam1iPLZcFs7bHmaSdwGKUk9-t0LJewcMhDlN9L4fGNQ&utm_content=271743104&utm_source=hs_email

The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00195-0/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-_G7Kh5duIx7ZyL-et1GYtXZbfIeZYOR5lkw0LfFavP8NBWdCQmIrwI_GsCn5AbGfFuNRYU2I3SkqQttKW9Fjm4biQRGA&utm_content=271743104&utm_source=hs_email

Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in England

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00116-3/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-_abEqAC3VFENZUm8GVPi7GZtXJvpYcH6KqPYMz6sfxUiuqDkEczTxIXXyGh0-0Zp5XqmXA5FvcZfhpYTpN1GFibIUQWg&utm_content=271743104&utm_source=hs_email

Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00129-1/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz--FiYzlbJWzz0UP3Ioyaig2ijI66AK2oJsk8Pzk9wifk8Q---M6dckr-AfVYHkLwS3XZwE01Yu-9Etl_COKiejnu0bxmg&utm_content=271743104&utm_source=hs_email

Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00154-7/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-_AnLGaNjcVogm_HmFcLZ8TiO8TUKFLXFE_9h9pLieDBM2q6-e2iCXPIY1VZW1vy0miqG-b3cOaTPyOQDbsHLZxBJHj7g&utm_content=271743104&utm_source=hs_email

Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00293-0/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-_8kp0vv53PsAoabHRlozp0PsbHg3zyABY7HOw9Bz-XGShsxHHnvIV98dzyJmUlaCiRY2OBzuX-7OYAzSYbhDsRTO5eaA&utm_content=271743104&utm_source=hs_email

Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK

https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00105-8/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-84y55cbeHkjeQWVHK3XLEk_EpZWtFrHg8BWa-Sze2iuGg_UUcGo4WJ7j77kEpdBkb1nMIcVKzsG4hDRab2f2mXftTztw&utm_content=271743104&utm_source=hs_email

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00171-4/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-8vE3cwR9KjbgKeMRFe9ako1e2MJjBAVPCvEFQIAhVzgXlfnCiMBb3tY_7kEkXyo4bUMymfwhifxrHQ2xjRpYeV4S1AaA&utm_content=271743104&utm_source=hs_email

Forming a consensus opinion to inform long COVID support mechanisms and interventions: a modified Delphi approach

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00322-X/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-9JFbOeHlPxUGQIfNkBygcUJBKSYh17ol_DCbbF26iW2vNXXeD_LrDPIdvm5N3_kak5mjkqwvM2kowbrGeJoYBx_Hgfaw&utm_content=271743104&utm_source=hs_email

Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00331-0/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-8xzZ1W5YF4CWKm_d2DzwFjIKHGML5Fj8SPHCxhXi_ePKRNExcb_GHl_xU51IX6MANmRS-vvQ5ZFfnJ94wwHbFX8RlONg&utm_content=271743104&utm_source=hs_email

Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00312-1/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-9eytpPmOKxcPezSOqc96WxaookEKuRjohjiPRP5XGirDfENEAGSLUa-2z9xQvZxrrXCKkI87czRR_OrmAW2YjdECgBkw&utm_content=271743104&utm_source=hs_email

The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action

https://www.thelancet.com/commission/sudden-cardiac-death?dgcid=hubspot_email_conferencealerts_lancetscd23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=271578212&_hsenc=p2ANqtz-_h65acqETUMmEBP6y__IUCcIMeQqTY9_d1dA5neViAnQJ-FK411BAy7sb6_QJrg0O15o4yYHxbokAgNMvy10vLsPX5bg&utm_content=271578212&utm_source=hs_email

Back to basics for out-of-hospital cardiac arrest

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01560-X/fulltext?dgcid=hubspot_email_conferencealerts_esc23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=271578212&_hsenc=p2ANqtz-_wz85Cm0pvAmJatEPSstkPtGCZjSarH4MncIHvP5nPxDQ948maAsYLspmgNkRRW2XFN7Pil-2na4FJOHcccVQaDkq-aA&utm_content=271578212&utm_source=hs_email

Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01351-X/fulltext?dgcid=hubspot_email_conferencealerts_esc23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=271578212&_hsenc=p2ANqtz-8pVvO1fUd3vvpGSmYavq_AMMWYtk9mlAoVBHtjnJmYNL69JFK0S7FPjv1p781NotsgffXFtXM92JgqbCC8y681aaS2SQ&utm_content=271578212&utm_source=hs_email

The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action

https://www.thelancet.com/commission/sudden-cardiac-death?dgcid=hubspot_email_conferencealerts_lancetscd23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=271578212&_hsenc=p2ANqtz-9vH__jJN3gEc4SSrJoMCXBW9hVv2OhgI4K-oJ1vwuzwK9dJtRpC-witf6Gop9zVPmBMNB3raRncuGK64V1YX0JCnjfmA&utm_content=271578212&utm_source=hs_email

sábado, 26 de agosto de 2023

Women with large vessel occlusion acute ischemic stroke are less likely to be routed to comprehensive stroke centers.

Women with large vessel occlusion acute ischemic stroke are less likely to be routed to comprehensive stroke centers. https://psnet.ahrq.gov/issue/women-large-vessel-occlusion-acute-ischemic-stroke-are-less-likely-be-routed-comprehensive Delayed diagnosis and treatment of stroke leads to adverse patient outcomes. This cross-sectional study identified gender disparities in the treatment of patients with large vessel occlusion (LVO) acute ischemic stroke (AIS), with women being less likely to be routed directly to comprehensive stroke centers compared with men, despite having more significant stroke syndromes.

The state of health, burnout, healthy behaviors, workplace wellness support, and concerns of medication errors in pharmacists during the COVID-19 pandemic.

The state of health, burnout, healthy behaviors, workplace wellness support, and concerns of medication errors in pharmacists during the COVID-19 pandemic. https://psnet.ahrq.gov/issue/state-health-burnout-healthy-behaviors-workplace-wellness-support-and-concerns-medication Many healthcare professionals experienced adverse emotional and psychological outcomes during the COVID-19 pandemic. This survey of 665 health system pharmacists found that pharmacists working in settings with higher levels of workplace wellness support were less likely to experience depression, anxiety, or burnout, and report higher levels of professional quality of life during the COVID-19 pandemic.

Perceptions of radiation safety culture in medical imaging by role.

Perceptions of radiation safety culture in medical imaging by role. https://psnet.ahrq.gov/issue/perceptions-radiation-safety-culture-medical-imaging-role Fostering a culture of safety is a core patient safety objective. This survey of 425 radiologic technologists explored differences in radiation safety culture between staff technologists and those in leadership roles. Findings identified several positional hierarchical imbalances in perceived determinants of safety culture, which could hinder efforts to establish a just culture and a positive organizational radiation safety culture.

Patient handoffs and multi-specialty trainee perspectives across an institution: informing recommendations for health systems and an expanded conceptual framework for handoffs.

Patient handoffs and multi-specialty trainee perspectives across an institution: informing recommendations for health systems and an expanded conceptual framework for handoffs. https://psnet.ahrq.gov/issue/patient-handoffs-and-multi-specialty-trainee-perspectives-across-institution-informing Standardizing handoff training in residency programs can lead to safer, more effective handoffs. Researchers surveyed a sample of 687 residents and fellows from over 30 specialties about handoff training perspectives. Participants reported wide variability in handoff content and identified important aspects of handoff training (critical handoff elements, the impact of systems-level factors, impact of the handoff on providers and patients, professional duty, and addressing blame or guilt related to poor handoff experiences).

Cognitive biases and moral characteristics of healthcare workers and their treatment approach for persons with advanced dementia in acute care settings.

Cognitive biases and moral characteristics of healthcare workers and their treatment approach for persons with advanced dementia in acute care settings. https://psnet.ahrq.gov/issue/cognitive-biases-and-moral-characteristics-healthcare-workers-and-their-treatment-approach Cognitive biases can influence treatment approach at the end of life. The goal of this study was to determine whether treatment approaches (e.g., palliative care to aggressive treatment) were associated with clinician cognitive biases in acute care settings for patients with advanced dementia and comorbidities. Representativeness, availability, and anchoring biases were associated with treatment approach in this hypothetical patient case; moral characteristics of the clinician were not associated with treatment approach.

Automated search methods for identifying wrong patient order entry-a scoping review.

https://psnet.ahrq.gov/issue/automated-search-methods-identifying-wrong-patient-order-entry-scoping-review Understanding causes of wrong-patient order entry (WPOE) can help develop interventions to reduce those medication errors. This review summarizes how organizations and providers identify WPOE, what data are being captured, and causes. The most common organizational detection method is the retract-and-reorder method whereby a medication order is cancelled then reordered on a different patient within a specified period of time. There was minimal data on how providers detect their own WPOE errors. Technology and physician workload were identified as contributors to WPOE.

A multi-facetted patient safety resource--a qualitative interview study on hospital managers' perception of the nurse-led Rapid Response Team.

https://psnet.ahrq.gov/issue/multi-facetted-patient-safety-resource-qualitative-interview-study-hospital-managers Rapid response teams (RRT) are activated, typically by nurses, when a patient demonstrates signs of imminent clinical deterioration, in order to prevent death or transfer to the intensive care unit (ICU). This study asks ICU managers about their perceptions of RRT beyond the stated goal of preventing patient deterioration. They describe the RRT as providing valuable education for new nurses and physicians and enhancing cohesion between the ICU and other wards. However, nurse managers stated they wanted more data and feedback from executive leadership.

Compliance with central line maintenance bundle and infection rates.

https://psnet.ahrq.gov/issue/compliance-central-line-maintenance-bundle-and-infection-rates Tripathi S, McGarvey J, Lee K, et al. Pediatrics. 2023;Epub Aug 4. Reducing central line-associated bloodstream infections (CLABSI) is an important patient safety improvement target. This study examined the relationship between compliance with evidence-based CLABSI guideline bundles and CLABSI rates in 159 hospitals. Between 2011 and 2021, researchers found that adherence to bundle guidelines was associated with a significant reduction in CLABSI rate.

Clinicians' insights on emergency department boarding: an explanatory mixed methods study evaluating patient care and clinician well-being.

https://psnet.ahrq.gov/issue/clinicians-insights-emergency-department-boarding-explanatory-mixed-methods-study-evaluating Loke DE, Green KA, Wessling EG, et al. Jt Comm J Qual Patient Saf. 2023;Epub Jul 2. Quantitative studies have demonstrated that emergency department (ED) overcrowding and patient boarding contribute to adverse events. This study includes both qualitative and quantitative methods to understand how ED clinicians view the impact of boarding on their own well-being as well as patient safety. Key themes include clinician dissatisfaction and burnout, and high rates of verbal and physical abuse from boarding patients. Possible solutions included improved standardization of care, proactive planning, and culture change hospital-wide.

Common contributing factors of diagnostic error: a retrospective analysis of 109 serious adverse event reports from Dutch hospitals.

https://psnet.ahrq.gov/issue/common-contributing-factors-diagnostic-error-retrospective-analysis-109-serious-adverse-event Hooftman J, Dijkstra AC, Suurmeijer I, et al. BMJ Qual Saf. 2023;Epub Aug 9. Diagnostic errors are common and have many contributing factors. This study analyzed more than 100 serious adverse event (SAE) reports in acute care using four investigation methods (e.g., Diagnostic Error Evaluation Research (DEER) taxonomy, Safer Dx Instrument) to identify common contributing factors. Transitions of care were particularly vulnerable to SAE, often due to incomplete communication between departments. Diagnostic errors occurred most often in the testing, assessment, and follow-up phases, with human factors as the most common contributing factor. Using multiple investigative methods supports more targeted interventions in each phase of diagnosis.

Grand challenges in bioinformatics education and training

https://pubmed.ncbi.nlm.nih.gov/37568018/

Spotlight on Child and Adolescent Health: closing the digital divide Wednesday, November 15, 2023 3:00 PM Greenwich Mean Time 1 hour, 15 minutes

Spotlight on Child and Adolescent Health: closing the digital divide Wednesday, November 15, 2023 3:00 PM Greenwich Mean Time 1 hour, 15 minutes https://event.on24.com/wcc/r/4279740/ED74EE5DF40E2E606B31A0BCF19B8D3C?partnerref=tlcom_lancetwebinarshub_lancet200_cah_webinar2 There is a bidirectional relationship between health and digital technology. Nowhere is the importance of digital spaces more apparent than amongst children and adolescents. This Lancet Webinar will explore why digital inclusion is a health issue, the barriers that prevent equitable access to digital tools, and propose solutions to make digital spaces more inclusive. The session will end with a live Q&A.

Spotlight on Research for Health: medical research as a catalyst for policy and societal change Thursday, November 09, 2023 1:30 PM Greenwich Mean Time 1 hour, 30 minutes

Spotlight on Research for Health: medical research as a catalyst for policy and societal change Thursday, November 09, 2023 1:30 PM Greenwich Mean Time 1 hour, 30 minutes https://event.on24.com/wcc/r/4277655/D9DE86EC6845C889A96A740097A4529C?partnerref=tlcom_lancetwebinarshub_lancet200_rh_webinar2 By effectively translating complex scientific concepts into accessible information, we can empower individuals and communities to make informed decisions that positively influence their health and wellbeing. In this thought-provoking Lancet Webinar, an expert panel will explore the profound impact that medical research can have on shaping policies and driving transformative societal change. The session will end with a live Q&A.

Spotlight on Mental Health: context and culture in mental health Tuesday, October 10, 2023 12:00 PM British Summer Time 1 hour, 30 minutes

Spotlight on Mental Health: context and culture in mental health Tuesday, October 10, 2023 12:00 PM British Summer Time 1 hour, 30 minutes https://event.on24.com/wcc/r/4277581/70218534D05D81238D99FF20C84A876A?partnerref=tlcom_lancetwebinarshub_lancet200_mh_webinar2 Psychiatry has been dominated by Western concepts throughout its modern history, and those concepts are integral to psychiatry training, research, and practice, as well as global mental health agendas in much of the world. In this Lancet Webinar, we will hear different perspectives from around the world on mental health, mental distress, and mental illness from outside of the dominant North American and European frameworks.

Public policy and health in the USA miniseries: should investors own healthcare? Tuesday, September 26, 2023 7:00 PM British Summer Time 1 hour

Public policy and health in the USA miniseries: should investors own healthcare? Tuesday, September 26, 2023 7:00 PM British Summer Time 1 hour https://event.on24.com/wcc/r/4261292/F83D33EB8BF67FD27D747E69F489D5E3?partnerref=tlcom_lancetwebinarshub_usinvestorshealthcare23 During this Lancet Webinar, a panel of US-based experts will examine the implications of growing investor ownership of physicians' practices, hospitals, and other health services in the USA, and their consolidation into giant corporate enterprises that dominate insurance and care delivery in many regions of the USA.

Spotlight on Universal Health Coverage: assessing expectations ahead of the UN High-Level Meeting on UHC Wednesday, September 06, 2023 1:00 PM British Summer Time 1 hour, 30 minutes

Spotlight on Universal Health Coverage: assessing expectations ahead of the UN High-Level Meeting on UHC Wednesday, September 06, 2023 1:00 PM British Summer Time 1 hour, 30 minutes https://event.on24.com/wcc/r/4275494/4063DA1B3D4FDA6B111A5BA1A546D6AD?partnerref=tlcom_lancetwebinarshub_lancet200_uhc_webinar1 Universal health coverage (UHC) is a key target of Sustainable Development Goal 3 and essential to the realisation of health for all. As stakeholders prepare for the second ever UN High-Level Meeting on UHC, this Lancet Webinar will bring together actors representing governments, donors, WHO, academia, and more to discuss their expectations and demands.Universal health coverage (UHC) is a key target of Sustainable Development Goal 3 and essential to the realisation of health for all. As stakeholders prepare for the second ever UN High-Level Meeting on UHC, this Lancet Webinar will bring together actors representing governments, donors, WHO, academia, and more to discuss their expectations and demands.

viernes, 25 de agosto de 2023

Real-World Opportunities and Challenges: Using NIMH’s Research Domain Criteria (RDoc) Framework in Global Mental Health Research September 20, 2023

Real-World Opportunities and Challenges: Using NIMH’s Research Domain Criteria (RDoc) Framework in Global Mental Health Research September 20, 2023 https://www.cgmhrwebinars.com/september-2023/ This webinar will discuss the National Institute of Mental Health’s Research Domain Criteria (RDoC) initiative and its potential to inform (and be informed by) global mental health research. RDoC is a research framework that encourages the investigation of mental disorders from a perspective of basic functional dimensions (e.g., cognitive control), using many types of information – from genomics and neuroscience to behavior and environmental measures.

Diagnosis and Treatment of Tethered Spinal Cord

https://effectivehealthcare.ahrq.gov/products/tethered-spinal-cord/protocol This review will summarize the evidence regarding diagnosis, prophylactic treatment, symptomatic treatment, and repeat surgery of tethered spinal cord. With funding from PCORI, AHRQ commissioned this work to synthesize the findings on the diagnosis and treatment of tethered spinal cord. The systematic review will support the Congress for Neurological Surgeons clinical practice guidelines.

Treatment of Stage I-III Squamous Cell Anal Cancer

Treatment of Stage I-III Squamous Cell Anal Cancer: This is an new protocol for a systematic review that will summarize the state of the evidence on treatment of stage I-III squamous cell carcinoma of the anal canal and anal margin. This systematic review will assess the effectiveness and harms of treatment for stages I-III squamous cell anal cancer. This review, funded by the Patient-Centered Outcomes Research Institute, will be used by the American Society of Clinical Oncology and the American Society of Radiation Oncology to update clinical practice guidelines.

Diagnosis and Management of Obsessive Compulsive Disorders in Children

Diagnosis and Management of Obsessive Compulsive Disorders in Children: The systematic review will summarize the findings from 1. Studies related to the accuracy of assessment tools compared to reference standard methods to identify OCD in symptomatic youth and 2. Studies of psychological and/or pharmacological treatments of OCD. This comparative effectiveness review will inform a planned update of the 2012 American Academy of Child and Adolescent Psychiatry (AACAP) Practice Parameter. AACAP nominated this topic to the Patient-Centered Outcomes Research Institute, which contracted with the Agency for Healthcare Research and Quality to conduct the review. Specifically, the systematic review will summarize the findings from 1. Studies related to the accuracy of assessment tools compared to reference standard methods to identify OCD in symptomatic youth and 2. Studies of psychological and/or pharmacological treatments of OCD. The intended audience includes guideline developers, child psychiatrists and psychologists, pediatricians, family physicians, advanced practice providers, parents, and patients.

Join us this fall to help enhance dementia study diversity

https://www.nia.nih.gov/research/blog/2023/08/join-us-fall-help-enhance-dementia-study-diversity?utm_source=NIA+Main&utm_campaign=c6f8201020-blog-ADstudydiversity-8-23&utm_medium=email&utm_term=0_-8180ce9847-%5BLIST_EMAIL_ID%5D Population and genetics studies can help us understand how genes and the environment affect aging-related health disparities. However, to gain meaningful insights that can benefit everyone, the research must reflect the diversity of today’s population. To address the gaps and meet the need for more inclusive studies, NIA will host a two-day hybrid workshop, The Future of Population-Based Studies in Alzheimer’s Disease and Related Dementia Research: Setting Future Scientific Priorities, Oct. 31 and Nov. 1.

Notes from the Field: Asthma-Associated Emergency Department Visits During a Wildfire Smoke Event — New York, June 2023 Weekly / August 25, 2023 / 72(34);933–935

Notes from the Field: Asthma-Associated Emergency Department Visits During a Wildfire Smoke Event — New York, June 2023 Weekly / August 25, 2023 / 72(34);933–935 https://www.cdc.gov/mmwr/volumes/72/wr/mm7234a6.htm?s_cid=mm7234a6_w&utm_campaign=morning_rounds&utm_medium=email&_hsmi=271672567&_hsenc=p2ANqtz--qTXXFUmFBrrjk_UxC3PEaWZqNo8UIdclu2xDhIu96IgU85KHJsahv0IAX_f9yli0R4OFg14G7VcTe_U8cakLpqEIUNw&utm_content=271672565&utm_source=hs_email

Asthma-Associated Emergency Department Visits During the Canadian Wildfire Smoke Episodes — United States, April– August 2023 Weekly / August 25, 2023 / 72(34);926–932

Asthma-Associated Emergency Department Visits During the Canadian Wildfire Smoke Episodes — United States, April– August 2023 Weekly / August 25, 2023 / 72(34);926–932 https://www.cdc.gov/mmwr/volumes/72/wr/mm7234a5.htm?s_cid=mm7234a5_w&utm_campaign=morning_rounds&utm_medium=email&_hsmi=271672567&_hsenc=p2ANqtz-9aBafOImjJz-pCiHqQm8MLdbShDdt918urzuqzjCqmkTcbdR0ilMOHpzmiY-eW3KW5y5EnYno4bUcRDO2xR36zu6EHuw&utm_content=271672565&utm_source=hs_email

What a review of gender-affirming care research by a top pediatrics group actually means Theresa Gaffney By Theresa Gaffney Aug. 25, 2023

https://www.statnews.com/2023/08/25/gender-affirming-care-aap-evidence/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=271672567&_hsenc=p2ANqtz-9I6rR1VqYFbyrvcypnjnqellpXs3dLtHsyZ0KPLdx5k2mRA8VMyXUSzhX8rj14hN9pt5r5ylZRrPMZ-mZEoIBi4YdUsg&utm_content=271672565&utm_source=hs_email

Follow the Military Health System on Social Media

https://health.mil/Military-Health-Topics/MHS-Toolkits/Social-Media?utm_medium=govdelivery&utm_source=email

Track Your Medications with TRICARE App Use the TRICARE Express Scripts Pharmacy app to learn about your medication and manage your prescription benefits.

Track Your Medications with TRICARE App Use the TRICARE Express Scripts Pharmacy app to learn about your medication and manage your prescription benefits. https://health.mil/News/Dvids-Articles/2023/08/17/news451554?utm_medium=govdelivery&utm_source=email

First nurse serves as director of ANG Medical Service Office of the Air Surgeon

https://www.af.mil/News/Article-Display/Article/3490935/first-nurse-serves-as-director-of-ang-medical-service-office-of-the-air-surgeon/

Military Health System Research Symposium Panel Focuses on Casualty Care Experts shared stories from the field: The “Casualty Care Across the Continuum: Operational Vignettes" panel kicked off the conference.Military Health System Research Symposium Panel Focuses on Casualty Care Experts shared stories from the field: The “Casualty Care Across the Continuum: Operational Vignettes" panel kicked off the conference.

Military Health System Research Symposium Panel Focuses on Casualty Care Experts shared stories from the field: The “Casualty Care Across the Continuum: Operational Vignettes" panel kicked off the conference. https://health.mil/News/Dvids-Articles/2023/08/16/news451474?utm_medium=govdelivery&utm_source=email

DHA Women's Equality Day Event Reveals Military History

DHA Women's Equality Day Event Reveals Military History Did you know that Harriet Tubman was a nurse during the Civil War? A National Museum of Health and Medicine expert spoke on the history and changing role of women in military medicine. https://health.mil/News/Dvids-Articles/2023/08/22/news451783?utm_medium=govdelivery&utm_source=email

New Prostate Cancer Treatments and Testing Guidelines

New Prostate Cancer Treatments and Testing Guidelines Promising new advancements can provide answers for one of the most common cancers in men. https://health.mil/News/Dvids-Articles/2023/08/17/news451457?utm_medium=govdelivery&utm_source=email

Defense Health Agency Leaders Release Strategic Plan

Defense Health Agency Leaders Release Strategic Plan New plan will “identify and leverage transformative technologies, expand partnerships, and adopt new models of health and wellness," said DHA Director U.S. Army Lt. Gen. Telita Crosland. https://health.mil/News/Dvids-Articles/2023/08/17/news451473?utm_medium=govdelivery&utm_source=email

Good Clinical Practice: Considerations for Trials with Pragmatic or Decentralized Features A Virtual Two-Day Meeting September 12 & 13 7:30 AM - 9:30 AM US Eastern

Good Clinical Practice: Considerations for Trials with Pragmatic or Decentralized Features A Virtual Two-Day Meeting September 12 & 13 7:30 AM - 9:30 AM US Eastern https://reaganudall.org/news-and-events/events/good-clinical-practice-considerations-trials-pragmatic-or-decentralized?utm_medium=email&utm_source=govdelivery Two-Day Virtual Public Meeting on Good Clinical Practice: Considerations for Clinical Trials with Decentralized or Pragmatic Features Join us on September 12 and 13, 2023, to explore good clinical practice considerations for clinical trials. The U.S. Food and Drug Administration, in collaboration with the Reagan-Udall Foundation for the FDA, will convene international experts in the conduct of clinical trials with pragmatic or decentralized features. Clinical trials with streamlined protocols that are embedded in existing health care infrastructure (often referred to as pragmatic trials), and trials with decentralized processes have the potential to generate evidence more efficiently while minimizing the burden on participants. Please save the date for this two-day, virtual public meeting: Tuesday, September 12 and Wednesday, September 13, 2023 7:30 a.m. – 9:30 a.m. ET (same time on both dates) Note that times are set to maximize global participation. Representatives from the research community will share their experiences conducting clinical trials with pragmatic or decentralized features. The two-day virtual public meeting will include presentations and moderated discussion to provide a better understanding of the opportunities and challenges of conducting trials with these innovative design features. Learnings from the meetings will inform the development of responsive policies and guidelines that encourage innovation, while protecting participants and safeguarding the reliability of trial results. You can contribute to the discussion. Share your questions when you register, and we’ll include as many as we can in the discussion. To register and submit questions, click here. The meeting agenda is available and will be updated as more information is provided. Full recordings of both sessions will be available after the meeting along with the complete slide deck and transcript.v

FDA Approves First Biosimilar to Treat Multiple Sclerosis Tyruko (natalizumab-sztn)

https://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimilar-treat-multiple-sclerosis?utm_medium=email&utm_source=govdelivery

Health equity is not possible without addressing disparities

https://pubmed.ncbi.nlm.nih.gov/37589700/

Medical Device Development Tools (MDDT)

https://www.fda.gov/medical-devices/medical-device-development-tools-mddt?utm_medium=email&utm_source=govdelivery#mddts

The effect of poverty on the relationship between household education levels and obesity in U.S. children and adolescents: an observational study Kosuke Inoue,Teresa E. Seeman,Roch Nianogo,Yusuke Okubo

The effect of poverty on the relationship between household education levels and obesity in U.S. children and adolescents: an observational study Kosuke Inoue,Teresa E. Seeman,Roch Nianogo,Yusuke Okubo https://www.thelancet.com/journals/lanam/inprogress?dgcid=hubspot_email_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-9h7F9Mz1PYMYbDFB4piAuvQ5hMOvG95GYC2e5HyxEWvaNpR6jiUjzhXi2lHyxIIGFxOHyqnGltLEe1zu8Rs4X5UELySQ&utm_content=271607792&utm_source=hs_email

Will it ever change? Lack of parental leave and its detrimental effects on maternal well-being Erin E.Y. Jefferson

Will it ever change? Lack of parental leave and its detrimental effects on maternal well-being Erin E.Y. Jefferson https://www.thelancet.com/journals/lanam/inprogress?dgcid=hubspot_email_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-9h7F9Mz1PYMYbDFB4piAuvQ5hMOvG95GYC2e5HyxEWvaNpR6jiUjzhXi2lHyxIIGFxOHyqnGltLEe1zu8Rs4X5UELySQ&utm_content=271607792&utm_source=hs_email

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study Dr Mahshid Dehghan et al.

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study Dr Mahshid Dehghan et al. https://www.thelancet.com/lancet-200/research-for-health?dgcid=hubspot_update_feature_lancet200_rfh_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-_E5j9SKa0it657ecbwvEafnj787uArnCSzofDxmvRxc_GQgbo9J-ToDtMsVNtYp8j6FBE0HKiFAvZ9KW3I-WyFSAhI5w&utm_content=271607792&utm_source=hs_email https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32252-3/fulltext

The Lancet Regional Health in conversation with

https://thelancetregionalhealth.buzzsprout.com/2223483/13277143-introducing-a-podcast-for-regional-voices?utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-8wzH7qjRFVhVdJs3OKE8sG8gqQMaCyTx_C2uc8KG7OnFrfRuL81NGAp8JT3Xsr4p3eqSQumiQ764q-dgqT8_TdGp3LwA&utm_content=271607792&utm_source=hs_email

Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00127-8/fulltext?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-95Bnn9ZjVkf69ia7awbLNRSn6JBeM6UY7mCBnyXUTBRPOWLurwJKvqTLcychakNn8-uJVKH6MakyHDnBoN1bC_rVvXpg&utm_content=271607792&utm_source=hs_email

What is the impact of the COVID-19 pandemic on tuberculosis?

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00360-1/fulltext COVID-19 Resource Centre https://www.thelancet.com/coronavirus?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-8NRQhs0ZjI8VIxZbZ3gtHFOb27U5lS2gVDYe5A0yGVdX42dof20iINqbJcLPE6WeUSPHsNbs4qHzCwdujR1wlLUETV9g&utm_content=271607792&utm_source=hs_email

Migrant youth after the US COVID-19 public health order

https://www.thelancet.com/coronavirus?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-8NRQhs0ZjI8VIxZbZ3gtHFOb27U5lS2gVDYe5A0yGVdX42dof20iINqbJcLPE6WeUSPHsNbs4qHzCwdujR1wlLUETV9g&utm_content=271607792&utm_source=hs_email

Association of sociocultural stressors with bipolar disorder onset in Puerto Rican youth growing up as members of a minoritized ethnic group: results from the Boricua Youth Longitudinal Study

Association of sociocultural stressors with bipolar disorder onset in Puerto Rican youth growing up as members of a minoritized ethnic group: results from the Boricua Youth Longitudinal Study https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00123-0/fulltext?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-8u-SgF5KoQa-oQqy9BVjF6nD7cSeWuLAs1vN2J7N9ag_A3fTpoRBgAR1-d-fW_14aUFFkHy01T_OLxb8ujzswk7s90fQ&utm_content=271607792&utm_source=hs_email

The burden of stomach cancer mortality by county, race, and ethnicity in the USA, 2000–2019: a systematic analysis of health disparities GBD US Health Disparities CollaboratorsThe burden of stomach cancer mortality by county, race, and ethnicity in the USA, 2000–2019: a systematic analysis of health disparities GBD US Health Disparities Collaborators

The burden of stomach cancer mortality by county, race, and ethnicity in the USA, 2000–2019: a systematic analysis of health disparities GBD US Health Disparities Collaborators https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00121-7/fulltext?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsmi=271627253&_hsenc=p2ANqtz-8xshzesKiIYc6rgqASrIJ4GJ2_djqvsNtOh4-_f4s_gAzsFvjUc-AwozH-KzNTzqToNFzpTQZOCrhIwD9IR85tl_MDig&utm_content=271607792&utm_source=hs_email

CDRHNew - News and Updates

https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrhnew-news-and-updates

What’s New for Biologics

https://www.fda.gov/vaccines-blood-biologics/news-events-biologics/whats-new-biologics?utm_medium=email&utm_source=govdelivery

NIST Announces First Four Quantum-Resistant Cryptographic Algorithms Federal agency reveals the first group of winners from its six-year competition.

NIST Announces First Four Quantum-Resistant Cryptographic Algorithms Federal agency reveals the first group of winners from its six-year competition. https://www.nist.gov/news-events/news/2022/07/nist-announces-first-four-quantum-resistant-cryptographic-algorithms

NIST to Standardize Encryption Algorithms That Can Resist Attack by Quantum Computers

NIST to Standardize Encryption Algorithms That Can Resist Attack by Quantum Computers Three new algorithms are expected to be ready for use in 2024. Others will follow. August 24, 2023 https://www.nist.gov/news-events/news/2023/08/nist-standardize-encryption-algorithms-can-resist-attack-quantum-computers

CAHPS Research Meetings: Patient Experience, Patient Safety, and Provider Well-Being: Associations and Paths for Quality Improvement (October 19, 2023) Date: October 19, 2023 Time: 11:00 am to 4:00 pm ET

CAHPS Research Meetings: AHRQ occasionally hosts research meetings that bring together researchers, subject matter experts and key stakeholders to focus on specific topics of interest related to CAHPS surveys. Patient Experience, Patient Safety, and Provider Well-Being: Associations and Paths for Quality Improvement (October 19, 2023) Date: October 19, 2023 Time: 11:00 am to 4:00 pm ET

jueves, 24 de agosto de 2023

After High School: Talking With Your Young Adult About Underage Drinking

https://store.samhsa.gov/product/after-high-school-talking-your-young-adult-about-underage-drinking/pep23-03-10-016?utm_source=SAMHSA&utm_campaign=582007af60-EMAIL_CAMPAIGN_2023_08_16_06_21&utm_medium=email&utm_term=0_-582007af60-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D

Talking With Your College-Bound Young Adult About Alcohol - The Sound of Your Voice: Parent Guide

https://store.samhsa.gov/product/talking-your-college-bound-young-adult-about-alcohol-sound-your-voice-parent-guide/pep23-03-10-017?utm_source=SAMHSA&utm_campaign=1a3a0dcf51-EMAIL_CAMPAIGN_2023_08_16_06_24&utm_medium=email&utm_term=0_-1a3a0dcf51-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D

SAMHSA Announces New Strategic Plan

SAMHSA Announces New Strategic Plan https://www.samhsa.gov/about-us/strategic-plan?utm_source=SAMHSA&utm_campaign=8b9f8e379a-EMAIL_CAMPAIGN_2023_08_14_03_08&utm_medium=email&utm_term=0_-8b9f8e379a-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D SAMHSA is pleased to announce the release of the agency’s 2023-2026 Strategic Plan which emphasizes a more person-centered approach and introduces a new mission and vision, key priorities and guiding principles. The key priorities are: Preventing Substance Use and Overdose Enhancing Access to Suicide Prevention and Mental Health Services Promoting Resilience and Emotional Health for Children, Youth and Families Integrating Behavioral and Physical Health Care Strengthening the Behavioral Health Workforce This plan not only represents SAMHSA’s thinking as an agency, but also reflects the insightful feedback received from the agency’s many stakeholders. https://www.samhsa.gov/sites/default/files/samhsa-strategic-plan.pdf?utm_source=SAMHSA&utm_campaign=8b9f8e379a-EMAIL_CAMPAIGN_2023_08_14_03_08&utm_medium=email&utm_term=0_-8b9f8e379a-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D

Back to School and Mental Health: Supporting Our Children for a Successful Year Ahead By: Sunny Patel, M.D., M.P.H., Center for Mental Health Services

Back to School and Mental Health: Supporting Our Children for a Successful Year Ahead By: Sunny Patel, M.D., M.P.H., Center for Mental Health Services https://www.samhsa.gov/blog/back-to-school-and-mental-health-supporting-children?utm_source=SAMHSA&utm_campaign=2482962d75-EMAIL_CAMPAIGN_2023_08_16_07_50&utm_medium=email&utm_term=0_-2482962d75-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D As the heat of the summer reaches its peak, and (hopefully soon) gives way to the cooler autumn breezes, it’s time for children and youth to return to school. As we prepare for the new academic year, it's crucial to remember that school readiness isn't just about having the right supplies, it's also about mental health. SAMHSA is committed to promoting mental health and preventing substance misuse as a critical part of overall health and wellness. As part of this commitment, we want to equip parents, teachers, and students with resources and tools to foster a mentally healthy return to school.

Insomnia, Hyperarousal, and Suicide in Psychosis — Webinar Friday, September 8, 2023 12 p.m. ET

Insomnia, Hyperarousal, and Suicide in Psychosis — Webinar Friday, September 8, 2023 12 p.m. ET https://education.smiadviser.org/Public/Catalog/Details.aspx?id=2qwmLTPKfZ288zgm103nQg%3d%3d&returnurl=%2fUsers%2fUserOnlineCourse.aspx%3fLearningActivityID%3d2qwmLTPKfZ288zgm103nQg%253d%253d&utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D Insomnia is common in schizophrenia. Insomnia has been associated with suicidal ideation and behavior, as well as greater severity of psychopathology, in schizophrenia. This presentation assesses the evidence regarding these associations and discusses the use of pupillometry as a novel marker of suicide risk in patients with psychiatric disorders.

Beyond Punishment: Building Bridges Through Restorative Justice — Webinar Thursday, September 7, 2023 3 p.m. ET

https://mhttcnetwork.org/centers/mountain-plains-mhttc/event/beyond-punishment-building-bridges-through-restorative-justice?utm_source=SAMHSA&utm_campaign=0dbad6c6f1-EMAIL_CAMPAIGN_2023_08_23_01_49&utm_medium=email&utm_term=0_-0dbad6c6f1-%5BLIST_EMAIL_ID%5D Join us for a dynamic professional development session focused on building a culture of accountability and empathy through Restorative Justice. In this engaging workshop, you will learn effective strategies to shift from punitive measures to empowerment, equipping you to guide students toward taking responsibility for their actions. Gain insights into reducing recurrent challenging behaviors, fostering student self-regulation and empathy, and cultivating open lines of communication and collaboration.